Pharmaceuticals News and Research

RSS

MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial

MAP Pharmaceuticals, Inc. today announced that the Company initiated a trial to compare the pharmacokinetics (PK), safety and metabolic profiles of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.

16 Feb 2010

Merck announces global sales of $27.4 billion for full-year 2009

Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov. 3, 2009 through Dec. 31, 2009.

16 Feb 2010

International Merchant Advisors signs LOI to purchase minority interest in Assured Pharmacy

International Merchant Advisors, Inc. www.imaiinc.com announced today that the company has signed a letter of intent to purchase a minority interest in Assured Pharmacy, Inc. www.assuredpharmacyinc.com, a retail pharmaceutical operation that is focused on selling prescription medications in the chronic pain management medical sector.

16 Feb 2010

BUSACC hosts breakfast panel over reconstruction opportunities in Iraq, covering healthcare and pharma

The reconstruction of Iraq is under way and opportunities for Texas businesses abound. The Bilateral U.S. – Arab Chamber of Commerce (BUSACC) is hosting a business breakfast and panel discussion featuring Iraq’s Ambassador to the United States, the Senior Commercial Counsel and a high level Ministry of Energy official and delegation, along with American risk and security mitigation experts.

16 Feb 2010

Linguamatics opens new regional headquarters in North America

Linguamatics, a leader in enterprise text mining, today announced expansion of its US-based operations and opening of a new North American regional headquarters. The company saw significant corporate growth in 2009, with the addition of new pharmaceutical customers combined with expansion in deployment of the I2E semantic knowledge-discovery platform within existing customers.

16 Feb 2010

Meda publishes 2009 year-end report

“The Meda Group expects to achieve sales of about SEK 13,000 million and an EBITDA of about SEK 4,200 million for full-year 2009.”

16 Feb 2010

VPCI pioneers on-demand GMP consultation services for Pharmaceutical manufacturers

Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service. Through the use of high definition video conferencing equipment and collaboration software, Pharmaceutical manufacturers now have access to GMP consultation services on-demand, and at a fraction of the cost.

16 Feb 2010

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.

16 Feb 2010

Abbott acquires Belgium-based Solvay Pharmaceuticals for $6.2 billion

Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.

16 Feb 2010

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries Ltd. today reported record results for the quarter and year ended December 31, 2009.

16 Feb 2010

NorTech announces winners of annual Innovation Awards program

NorTech, in partnership with Crain's Cleveland Business, is pleased to announce the winners of its annual Innovation Awards program which honors the achievements of Northeast Ohio's most innovative organizations and leaders.

16 Feb 2010

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva’s U.S. generic version of Novartis’ Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.

16 Feb 2010

Albemarle, Pharmacore partner to provide manufacturing capabilities for high volume capacity projects

Albemarle Corporation, a leading global provider of custom manufacturing services, announced today it will partner with PharmaCore to provide manufacturing capabilities for customers with projects that require high volume capacity.

16 Feb 2010

Researchers discover new mechanism within human cells that constantly protects against disease

Researchers at Oregon Health & Science University have discovered a new mechanism within human cells that constantly protects us against disease. P. Michael Conn, Ph.D., a researcher at the OHSU Oregon National Primate Research Center directed the work. The findings are reported in the Feb. 15 issue of the journal Proceedings of the National Academy of Sciences.

16 Feb 2010

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Medivir and Meda today announced an agreement for the commercialization of Medivir’s cold sore product which will be marketed in North America under the trade name Xerese™.

15 Feb 2010

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

15 Feb 2010

TVM Capital MENA receives DFSA approval to start regional healthcare growth capital fund

TVM Capital MENA today announced that it has received the approval of the Dubai Financial Services Authority (DFSA) to start operation of its first regional healthcare growth capital fund with US$40 million of subscriptions from founding investors, Saudi Health Investment Company (SHIC), the International Finance Corporation (IFC), and GE Healthcare. TVM Capital MENA Ltd., the fund’s operator, is based in the Dubai International Financial Centre (DIFC) and is licensed and regulated by the DFSA.

15 Feb 2010

Bioniche Life Sciences meets obligations under licensing agreement with Endo Pharmaceuticals

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced that it has met the obligations associated with two milestones under its licensing agreement with Endo Pharmaceuticals for exclusive rights to develop and market Bioniche's proprietary product for non-muscle-invasive bladder cancer in North America.

15 Feb 2010

National MS Society launches We Keep Moving campaign to capture stories of people living with MS

For every person living with and affected by MS there is a unique story about how they move forward with their lives. That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS

15 Feb 2010

Phrma's Tauzin quits amid talk that White House deal caused tension within organization

Former congressman and powerful lobbyist Billy Tauzin is resigning as head of the pharmaceutical industry trade group after a deal he helped broker with the White House on health reform strained relationships inside the group.

15 Feb 2010

Pharmaceuticals News and Research

MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial

Merck announces global sales of $27.4 billion for full-year 2009

International Merchant Advisors signs LOI to purchase minority interest in Assured Pharmacy

BUSACC hosts breakfast panel over reconstruction opportunities in Iraq, covering healthcare and pharma

Linguamatics opens new regional headquarters in North America

Meda publishes 2009 year-end report

VPCI pioneers on-demand GMP consultation services for Pharmaceutical manufacturers

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

Abbott acquires Belgium-based Solvay Pharmaceuticals for $6.2 billion

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

NorTech announces winners of annual Innovation Awards program

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Albemarle, Pharmacore partner to provide manufacturing capabilities for high volume capacity projects

Researchers discover new mechanism within human cells that constantly protects against disease

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

TVM Capital MENA receives DFSA approval to start regional healthcare growth capital fund

Bioniche Life Sciences meets obligations under licensing agreement with Endo Pharmaceuticals

National MS Society launches We Keep Moving campaign to capture stories of people living with MS

Phrma's Tauzin quits amid talk that White House deal caused tension within organization

A guide to density measurement excellence eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence